Plasmonix
Baltimore
About Plasmonix
Plasmonix is a biotechnology company that commercializes Metal Enhanced Fluorescence (MEF) technology to transform the use of fluorescence and luminescence which enhances the emitted light signal, facilitating detection to as low as several hundred molecules, which was heretofore not possible. The company also develops cell lysis device that uses microwave energy to break open the contents of bacteria and cells to enable detection of their molecular contents and genetic fingerprint. Plasmonix was incorporated in 2009 and is based in Baltimore, Maryland
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.9M
- Funding stage: Seed
- Last round: Seed (Jun 2014)
- Website: plasmonixinc.com
- Phone: 410-625-5939
Industries & Categories
Biotechnology, Genetics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/plasmonix-3368708 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.